Impact of Targeted Therapy on Outcome of Chronic Lymphocytic Leukemia Patients with Relapsed Del(17p13.1) Karyotype at a Single Center

Documenti analoghi

• Externally validated predictive clinical model for untreated del(17p13.1) chronic lymphocytic leukemia patients
  di: Stephens, Deborah M., et al.
  Pubblicazione: (2015)
• Complex karyotype predicts for inferior outcomes following reduced-intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia
  di: Jaglowski, Samantha M., et al.
  Pubblicazione: (2012)
• Outcome of Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) Treated with Flavopiridol: Impact of Genetic Features
  di: Woyach, Jennifer A., et al.
  Pubblicazione: (2012)
• Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemia
  di: Heerema, Nyla A., et al.
  Pubblicazione: (2020)
• Etiology of Ibrutinib Discontinuation and Outcomes in Chronic Lymphocytic Leukemia Patients
  di: Maddocks, Kami J., et al.
  Pubblicazione: (2015)